Kindred Biosciences OverviewKindred Biosciences EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KIN.
Quarterly EBIT
-$8.54M
↓ 135.53% YoY
As of Jun 30, 2021
Annual EBIT (TTM)
-$40.28M
↓ 37.13% YoY
Trailing 12 months ending Jun 30, 2021
Kindred Biosciences OverviewEBIT (Earnings Before Interest and Taxes) analysis for KIN.
As of Jun 30, 2021
Trailing 12 months ending Jun 30, 2021